The 33rd China International Bicycle Fair 2025 Set to Grandly Open

2025-03-25 HaiPress

One of the most influential events in the global bicycle industry, the 33rd China International Bicycle Fair (China Cycle 2025), will be held from May 5-8, 2025, at the Shanghai New International Expo Centre (SNIEC), China. Under the theme "Empowering Innovation, Sharing the Future", the exhibition will bring together industry leaders from around the world to explore new opportunities for innovation and collaboration.

As a barometer of the global bicycle industry, China Cycle has successfully held over thirty editions, continuously expanding in scale and influence. In 2024, the exhibition covered 150,000 m2, attracting 1,460 exhibitors and nearly 200,000 visitors from 137 countries and regions. China Cycle 2025 is set to elevate the event further with an expanded platform, optimized layout, and enhanced services, showcasing the latest technologies, products, and market trends in the global bicycle and e-bike sector.

With the global bicycle industry on a recovery path, China’s bicycle sector is experiencing particularly strong growth, bringing renewed confidence to the industry. China Cycle 2025 will stay aligned with industry trends by expanding exhibition space, optimizing the event structure, and facilitating deeper integration of the global supply and value chains, providing exhibitors and visitors with more comprehensive networking and business opportunities.

To ensure a successful event, the organizing committee is making every effort to curate a dynamic exhibition, featuring professional forums, industry summits, new product launches, and interactive experiences. The exhibition will present a more open, professional, and engaging experience, creating valuable opportunities for industry professionals worldwide.

From May 5-8, 2025, China Cycle 2025 looks forward to welcoming global industry partners to Shanghai to witness the future of the bicycle industry together!

dde9cf6d-61d8-4859-8d87-760fd85e4f9a

Company:Shanghai OTOBTB Cultural Development Co.,Ltd
Contact Person:Kira Pan
Email:kira.pan@otobtb.com
Website:http://www.otobtb.com
Telephone:021-32513000-859
City:Shanghai

Disclaimer: This article is reproduced from other media. The purpose of reprinting is to convey more information. It does not mean that this website agrees with its views and is responsible for its authenticity, and does not bear any legal responsibility. All resources on this site are collected on the Internet. The purpose of sharing is for everyone's learning and reference only. If there is copyright or intellectual property infringement, please leave us a message.

Newest

1Cangxi County Holds 2026 New Year's Cultural Performance for the Public

Cangxi County Holds 2026 New Year's Cultural Performance for the Public

2The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

3The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

4Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange

Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange

5Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference

Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference

6Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement

Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement

©copyright2009-2020Fresh life